USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment

Endometrial adenocarcinoma is the most common gynecologic malignancy in the United States. Most endometrial cancer cases are diagnosed at an early stage and have good prognosis. Unfortunately a subset of patients with early stage and low grade disease experience recurrence for reasons that remain un...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Vogel, Rachel Isaksson, Pulver, Tanya, Heilmann, Wiebke, Mooneyham, Ashley, Mullany, Sally, Zhao, Xianda, Shahi, Maryam, Richter, James, Klein, Molly, Chen, Liqiang, Ding, Rui, Konecny, Gottfried, Kommoss, Stefan, Winterhoff, Boris, Ghebre, Rahel, Bazzaro, Martina
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058731/
https://ncbi.nlm.nih.gov/pubmed/27121063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8821
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares